Disc Biacuplasty

The biacuplasty procedure was developed in order to treat individuals suffering from chronic discogenic back pain originating from annular fissures or contained disc herniations. Patients with chronic discogenic pain who have attempted pain relief with medications and injections without adequate attenuation of pain may be good candidates for this procedure.

This biacuplasty procedure is a minimally invasive percutaneous procedure which uses internally cooled radiofrequency probes to lesion the nociceptors in the intervertebral disc.




© Copyright Baylis Medical Company Inc., 2006

The BMC logo, TransDiscal and TransDiscal System are trademarks or registered trademarks of Baylis Medical Company Inc. in the United States and/or other countries.

Baylis Medical Company Inc. reserves the right to change specifications or to incorporate design changes without notice and without incurring any obligation relating to equipment previously manufactured or delivered

Caution : Federal Law (USA) restricts the sale of these devices to or by the order of a physician.

Patents Pending and/or issued

Warning: Google Translate™ automatic translation is provided as a service only. Baylis Medical is not to be held responsible for translation errors in languages other than English. Only the English version of this site should be considered accurate.









Patient selection for disc biacuplasty

Inclusion Criteria

Patients must meet all of the inclusion criteria:

  • Criteria for discogenic pain satisfied, viz
    • Predominant axial / mechanical pain
    • Demonstration of positive concordant pain of intensity >6/10 during provocative lumbar discography at 1 or 2 disc levels at low pressures (<50 psi) with negative control disc at one and preferably two adjacent levels and sham pressurization
    • Physical examination
  • Chronic pain (>6 months)
  • Age greater than 18 years
  • At least 50% preserved disc height
  • Failure to achieve adequate improvement with comprehensive non-operative treatment including: non-steroidal anti-inflammatory drugs, physical therapy, and fluoroscopically guided epidural steroid injection in and around the area of pathology
  • Other possible causes of low back pain have been ruled out e.g. failure to obtain prolonged improvement (> 14 days) from facet injections, sacroiliac joint injections or RF rhizotomies

Exclusion Criteria

Patients will be excluded if they meet any of the following criteria:

  • Neurological deficit
  • Intervertebral disc herniations greater than 4mm
  • Extruded/sequestered intervertebral disc herniations
  • Spinal pathology that may impede recovery e.g. spina bifida occulta, spondylolisthesis at the painful segmental level, or scoliosis
  • Moderate to severe foraminal or central canal stenosis
  • Pregnancy
  • Existing endplate damage or Schmorl’s nodes
  • Greater than grade 4 annular tear (Modified Dallas Grading)
  • Systemic infection or localized infection at the anticipated introducer entry site
  • History of coagulopathy or unexplained bleeding

Relative Contraindications

  • Body Mass Index greater than 29.9 (obese)
  • Irreversible psychological barriers to recovery
  • Prior lumbar spine surgery
  • Radiculopathy
  • Immunosuppression (e.g. AIDS, cancer, diabetes, other surgery within last 3 months)

Potential risks

As with any medical procedure there are risks. However, since the biacuplasty procedure is minimally invasive, the risks are lower than surgery.

Potential risks include:

  • In rare cases, radiofrequency procedures have caused burns at the site of insertion of the introducer needles
  • Due to the rarity of these cases it is believed that such events may be caused by operator error
  • Nerve injury is a potential risk of the procedure. However, having the patient in a state of conscious sedation, where they are able to verbally communicate any unwanted sensations reduces the risk of this occurrence
















AP fluoroscopic view of the TransDiscal Probes placed in an L5-S1 disc courtesy of J.D. Petersohn, MD


For a better Web page viewing experience, click here